LYONDELLBASELL INDU-CL A (LYB) Stock Fundamental Analysis

NYSE:LYB • NL0009434992

57.52 USD
+1.22 (+2.17%)
At close: Feb 27, 2026
56.76 USD
-0.76 (-1.32%)
Pre-Market: 3/2/2026, 7:00:00 AM
Fundamental Rating

3

Taking everything into account, LYB scores 3 out of 10 in our fundamental rating. LYB was compared to 83 industry peers in the Chemicals industry. LYB may be in some trouble as it scores bad on both profitability and health. LYB has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year LYB was profitable.
  • LYB had a positive operating cash flow in the past year.
  • Of the past 5 years LYB 4 years were profitable.
  • In the past 5 years LYB always reported a positive cash flow from operatings.
LYB Yearly Net Income VS EBIT VS OCF VS FCFLYB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B

1.2 Ratios

  • Looking at the Return On Assets, with a value of -2.21%, LYB is doing worse than 61.45% of the companies in the same industry.
  • The Return On Equity of LYB (-7.46%) is worse than 63.86% of its industry peers.
  • LYB's Return On Invested Capital of 2.51% is on the low side compared to the rest of the industry. LYB is outperformed by 61.45% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for LYB is in line with the industry average of 6.19%.
  • The 3 year average ROIC (6.66%) for LYB is well above the current ROIC(2.51%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -2.21%
ROE -7.46%
ROIC 2.51%
ROA(3y)2.42%
ROA(5y)6.64%
ROE(3y)6.57%
ROE(5y)19.56%
ROIC(3y)6.66%
ROIC(5y)11.12%
LYB Yearly ROA, ROE, ROICLYB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

1.3 Margins

  • LYB has a Operating Margin of 2.76%. This is in the lower half of the industry: LYB underperforms 65.06% of its industry peers.
  • In the last couple of years the Operating Margin of LYB has declined.
  • LYB's Gross Margin of 8.55% is on the low side compared to the rest of the industry. LYB is outperformed by 83.13% of its industry peers.
  • LYB's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.76%
PM (TTM) N/A
GM 8.55%
OM growth 3Y-35.45%
OM growth 5Y-18.61%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.25%
GM growth 5Y-6.92%
LYB Yearly Profit, Operating, Gross MarginsLYB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15 20

3

2. Health

2.1 Basic Checks

  • LYB has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • LYB has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, LYB has less shares outstanding
  • The debt/assets ratio for LYB is higher compared to a year ago.
LYB Yearly Shares OutstandingLYB Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
LYB Yearly Total Debt VS Total AssetsLYB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.2 Solvency

  • An Altman-Z score of 1.88 indicates that LYB is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • LYB has a Altman-Z score (1.88) which is comparable to the rest of the industry.
  • LYB has a debt to FCF ratio of 33.69. This is a negative value and a sign of low solvency as LYB would need 33.69 years to pay back of all of its debts.
  • LYB has a Debt to FCF ratio of 33.69. This is comparable to the rest of the industry: LYB outperforms 44.58% of its industry peers.
  • A Debt/Equity ratio of 1.22 is on the high side and indicates that LYB has dependencies on debt financing.
  • With a Debt to Equity ratio value of 1.22, LYB is not doing good in the industry: 71.08% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.22
Debt/FCF 33.69
Altman-Z 1.88
ROIC/WACC0.33
WACC7.61%
LYB Yearly LT Debt VS Equity VS FCFLYB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.3 Liquidity

  • A Current Ratio of 1.77 indicates that LYB should not have too much problems paying its short term obligations.
  • LYB has a Current ratio (1.77) which is in line with its industry peers.
  • A Quick Ratio of 1.20 indicates that LYB should not have too much problems paying its short term obligations.
  • LYB's Quick ratio of 1.20 is in line compared to the rest of the industry. LYB outperforms 45.78% of its industry peers.
Industry RankSector Rank
Current Ratio 1.77
Quick Ratio 1.2
LYB Yearly Current Assets VS Current LiabilitesLYB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

3

3. Growth

3.1 Past

  • LYB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -73.44%.
  • The earnings per share for LYB have been decreasing by -21.44% on average. This is quite bad
  • The Revenue for LYB has decreased by -25.18% in the past year. This is quite bad
  • Measured over the past years, LYB shows a small growth in Revenue. The Revenue has been growing by 1.67% on average per year.
EPS 1Y (TTM)-73.44%
EPS 3Y-48.49%
EPS 5Y-21.44%
EPS Q2Q%-134.67%
Revenue 1Y (TTM)-25.18%
Revenue growth 3Y-15.77%
Revenue growth 5Y1.67%
Sales Q2Q%-25.33%

3.2 Future

  • LYB is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 48.11% yearly.
  • Based on estimates for the next years, LYB will show a decrease in Revenue. The Revenue will decrease by -0.68% on average per year.
EPS Next Y58.88%
EPS Next 2Y51.34%
EPS Next 3Y45.54%
EPS Next 5Y48.11%
Revenue Next Year-1.35%
Revenue Next 2Y-0.34%
Revenue Next 3Y0.86%
Revenue Next 5Y-0.68%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
LYB Yearly Revenue VS EstimatesLYB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10B 20B 30B 40B 50B
LYB Yearly EPS VS EstimatesLYB Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5 10 15

4

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 33.84, LYB can be considered very expensive at the moment.
  • Compared to the rest of the industry, the Price/Earnings ratio of LYB is on the same level as its industry peers.
  • When comparing the Price/Earnings ratio of LYB to the average of the S&P500 Index (27.07), we can say LYB is valued slightly more expensively.
  • The Price/Forward Earnings ratio is 21.30, which indicates a rather expensive current valuation of LYB.
  • LYB's Price/Forward Earnings ratio is in line with the industry average.
  • LYB's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.05.
Industry RankSector Rank
PE 33.84
Fwd PE 21.3
LYB Price Earnings VS Forward Price EarningsLYB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of LYB is on the same level as its industry peers.
  • LYB's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 48.23
EV/EBITDA 12.51
LYB Per share dataLYB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

  • LYB's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as LYB's earnings are expected to grow with 45.54% in the coming years.
PEG (NY)0.57
PEG (5Y)N/A
EPS Next 2Y51.34%
EPS Next 3Y45.54%

6

5. Dividend

5.1 Amount

  • LYB has a Yearly Dividend Yield of 4.90%, which is a nice return.
  • LYB's Dividend Yield is rather good when compared to the industry average which is at 2.19. LYB pays more dividend than 90.36% of the companies in the same industry.
  • LYB's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 4.9%

5.2 History

  • The dividend of LYB has a limited annual growth rate of 5.33%.
  • LYB has paid a dividend for at least 10 years, which is a reliable track record.
  • The dividend of LYB decreased recently.
Dividend Growth(5Y)5.33%
Div Incr Years1
Div Non Decr Years1
LYB Yearly Dividends per shareLYB Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6 8

5.3 Sustainability

  • LYB has negative earnings and hence a negative payout ratio. The dividend may be in danger.
  • LYB's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-234.57%
EPS Next 2Y51.34%
EPS Next 3Y45.54%
LYB Yearly Income VS Free CF VS DividendLYB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B

LYONDELLBASELL INDU-CL A

NYSE:LYB (2/27/2026, 8:16:18 PM)

Premarket: 56.76 -0.76 (-1.32%)

57.52

+1.22 (+2.17%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)01-30
Earnings (Next)04-23
Inst Owners71.84%
Inst Owner Change2.66%
Ins Owners0.18%
Ins Owner Change0%
Market Cap18.52B
Revenue(TTM)30.15B
Net Income(TTM)-752.00M
Analysts52.14
Price Target52.2 (-9.25%)
Short Float %8.43%
Short Ratio3.47
Dividend
Industry RankSector Rank
Dividend Yield 4.9%
Yearly Dividend5.46
Dividend Growth(5Y)5.33%
DP-234.57%
Div Incr Years1
Div Non Decr Years1
Ex-Date03-02
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-137.75%
Min EPS beat(2)-299.66%
Max EPS beat(2)24.17%
EPS beat(4)1
Avg EPS beat(4)-80.58%
Min EPS beat(4)-299.66%
Max EPS beat(4)24.17%
EPS beat(8)3
Avg EPS beat(8)-39.32%
EPS beat(12)7
Avg EPS beat(12)-20.1%
EPS beat(16)10
Avg EPS beat(16)-15.37%
Revenue beat(2)2
Avg Revenue beat(2)3.27%
Min Revenue beat(2)3.26%
Max Revenue beat(2)3.27%
Revenue beat(4)4
Avg Revenue beat(4)2.27%
Min Revenue beat(4)0.76%
Max Revenue beat(4)3.27%
Revenue beat(8)7
Avg Revenue beat(8)1.06%
Revenue beat(12)8
Avg Revenue beat(12)0.1%
Revenue beat(16)10
Avg Revenue beat(16)0.24%
PT rev (1m)4.66%
PT rev (3m)-6.07%
EPS NQ rev (1m)-69.14%
EPS NQ rev (3m)-74.89%
EPS NY rev (1m)-16.08%
EPS NY rev (3m)-31.82%
Revenue NQ rev (1m)0.86%
Revenue NQ rev (3m)-0.55%
Revenue NY rev (1m)-0.38%
Revenue NY rev (3m)-1.16%
Valuation
Industry RankSector Rank
PE 33.84
Fwd PE 21.3
P/S 0.61
P/FCF 48.23
P/OCF 8.19
P/B 1.84
P/tB 2.08
EV/EBITDA 12.51
EPS(TTM)1.7
EY2.96%
EPS(NY)2.7
Fwd EY4.7%
FCF(TTM)1.19
FCFY2.07%
OCF(TTM)7.02
OCFY12.21%
SpS93.64
BVpS31.31
TBVpS27.71
PEG (NY)0.57
PEG (5Y)N/A
Graham Number34.61
Profitability
Industry RankSector Rank
ROA -2.21%
ROE -7.46%
ROCE 2.98%
ROIC 2.51%
ROICexc 2.86%
ROICexgc 3%
OM 2.76%
PM (TTM) N/A
GM 8.55%
FCFM 1.27%
ROA(3y)2.42%
ROA(5y)6.64%
ROE(3y)6.57%
ROE(5y)19.56%
ROIC(3y)6.66%
ROIC(5y)11.12%
ROICexc(3y)7.53%
ROICexc(5y)12.09%
ROICexgc(3y)8.19%
ROICexgc(5y)13.23%
ROCE(3y)7.89%
ROCE(5y)13.24%
ROICexgc growth 3Y-44.26%
ROICexgc growth 5Y-15.95%
ROICexc growth 3Y-43.41%
ROICexc growth 5Y-15.05%
OM growth 3Y-35.45%
OM growth 5Y-18.61%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.25%
GM growth 5Y-6.92%
F-Score3
Asset Turnover0.89
Health
Industry RankSector Rank
Debt/Equity 1.22
Debt/FCF 33.69
Debt/EBITDA 5.56
Cap/Depr 135.11%
Cap/Sales 6.23%
Interest Coverage 1.72
Cash Conversion 101.85%
Profit Quality N/A
Current Ratio 1.77
Quick Ratio 1.2
Altman-Z 1.88
F-Score3
WACC7.61%
ROIC/WACC0.33
Cap/Depr(3y)118.58%
Cap/Depr(5y)129.11%
Cap/Sales(3y)5.44%
Cap/Sales(5y)4.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-73.44%
EPS 3Y-48.49%
EPS 5Y-21.44%
EPS Q2Q%-134.67%
EPS Next Y58.88%
EPS Next 2Y51.34%
EPS Next 3Y45.54%
EPS Next 5Y48.11%
Revenue 1Y (TTM)-25.18%
Revenue growth 3Y-15.77%
Revenue growth 5Y1.67%
Sales Q2Q%-25.33%
Revenue Next Year-1.35%
Revenue Next 2Y-0.34%
Revenue Next 3Y0.86%
Revenue Next 5Y-0.68%
EBIT growth 1Y-69.96%
EBIT growth 3Y-45.63%
EBIT growth 5Y-17.24%
EBIT Next Year119.8%
EBIT Next 3Y44.55%
EBIT Next 5Y39.77%
FCF growth 1Y-80.61%
FCF growth 3Y-55.05%
FCF growth 5Y-23.41%
OCF growth 1Y-40.77%
OCF growth 3Y-28.23%
OCF growth 5Y-7.85%

LYONDELLBASELL INDU-CL A / LYB FAQ

Can you provide the ChartMill fundamental rating for LYONDELLBASELL INDU-CL A?

ChartMill assigns a fundamental rating of 3 / 10 to LYB.


What is the valuation status of LYONDELLBASELL INDU-CL A (LYB) stock?

ChartMill assigns a valuation rating of 4 / 10 to LYONDELLBASELL INDU-CL A (LYB). This can be considered as Fairly Valued.


How profitable is LYONDELLBASELL INDU-CL A (LYB) stock?

LYONDELLBASELL INDU-CL A (LYB) has a profitability rating of 3 / 10.


How financially healthy is LYONDELLBASELL INDU-CL A?

The financial health rating of LYONDELLBASELL INDU-CL A (LYB) is 3 / 10.


What is the earnings growth outlook for LYONDELLBASELL INDU-CL A?

The Earnings per Share (EPS) of LYONDELLBASELL INDU-CL A (LYB) is expected to grow by 58.88% in the next year.